EE05864B1 - 3-hüdroksütsüklopentoonitsüklit sisaldava ühendi kompositsioon ja meetod selle stabiliseerimiseks - Google Patents

3-hüdroksütsüklopentoonitsüklit sisaldava ühendi kompositsioon ja meetod selle stabiliseerimiseks

Info

Publication number
EE05864B1
EE05864B1 EEP202100026A EEP202100026A EE05864B1 EE 05864 B1 EE05864 B1 EE 05864B1 EE P202100026 A EEP202100026 A EE P202100026A EE P202100026 A EEP202100026 A EE P202100026A EE 05864 B1 EE05864 B1 EE 05864B1
Authority
EE
Estonia
Prior art keywords
composition
hydroxycyclopentanone
moiety
compound
stabilization
Prior art date
Application number
EEP202100026A
Other languages
English (en)
Inventor
Ivar JÄRVING
Original Assignee
Aktsiaselts Kevelt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktsiaselts Kevelt filed Critical Aktsiaselts Kevelt
Priority to EEP202100026A priority Critical patent/EE05864B1/et
Priority to PCT/IB2022/062615 priority patent/WO2023119188A1/en
Publication of EE202100026A publication Critical patent/EE202100026A/et
Publication of EE05864B1 publication Critical patent/EE05864B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Leiutis käsitleb kompositsiooni, mis sisaldab 3-hüdroksütsüklopentanoonitsüklit sisaldavat ühendit, alkoholi või estrit või nende segu sisaldavat lahustit ning soola, mis on võimeline lahustis dissotsieeruma, või seda moodustavaid ioone. Lisaks käsitleb leiutis sellist kompositsiooni sisaldavat komplekti, meetodit kompositsiooni valmistamiseks ja meetodit 3-hüdroksütsüklopentanoonitsüklit sisaldava ühendi stabiliseerimiseks lahustis, kasutades soola.
EEP202100026A 2021-12-22 2021-12-22 3-hüdroksütsüklopentoonitsüklit sisaldava ühendi kompositsioon ja meetod selle stabiliseerimiseks EE05864B1 (et)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EEP202100026A EE05864B1 (et) 2021-12-22 2021-12-22 3-hüdroksütsüklopentoonitsüklit sisaldava ühendi kompositsioon ja meetod selle stabiliseerimiseks
PCT/IB2022/062615 WO2023119188A1 (en) 2021-12-22 2022-12-21 Composition of compound comprising 3-hydroxycyclopentanone moiety and method of its stabilization

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EEP202100026A EE05864B1 (et) 2021-12-22 2021-12-22 3-hüdroksütsüklopentoonitsüklit sisaldava ühendi kompositsioon ja meetod selle stabiliseerimiseks

Publications (2)

Publication Number Publication Date
EE202100026A EE202100026A (et) 2023-08-15
EE05864B1 true EE05864B1 (et) 2024-02-15

Family

ID=86901468

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP202100026A EE05864B1 (et) 2021-12-22 2021-12-22 3-hüdroksütsüklopentoonitsüklit sisaldava ühendi kompositsioon ja meetod selle stabiliseerimiseks

Country Status (2)

Country Link
EE (1) EE05864B1 (et)
WO (1) WO2023119188A1 (et)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3851052A (en) * 1972-11-08 1974-11-26 Pfizer Stabilized e-series prostaglandins
US4301175A (en) * 1980-12-29 1981-11-17 The Upjohn Company E-Type prostaglandin compositions
WO2015113094A1 (de) * 2014-01-30 2015-08-06 Gebro Holding Gmbh Stabile alkoholische lösung von alprostadil
WO2017015690A1 (de) * 2015-07-27 2017-02-02 Gebro Holding Gmbh Konzentrat enthaltend alprostadil

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954787A (en) * 1974-06-18 1976-05-04 Pfizer Inc. Stabilized E-series prostaglandins
US4070242A (en) * 1977-03-23 1978-01-24 Miles Laboratories, Inc. Method for the preparation of prostaglandin synthetase
US20050020646A1 (en) * 2003-06-25 2005-01-27 Pfizer Inc. Treatment of BPH
AT517555A1 (de) * 2015-07-27 2017-02-15 Gebro Holding Gmbh Konzentrat enthaltend Alprostadil
RU2695068C1 (ru) * 2018-06-26 2019-07-19 Общество с ограниченной ответственностью "Гурус БиоФарм" Средство для лечения хронических облитерирующих заболеваний периферических сосудов на основе простагландина
CN110193084A (zh) * 2019-07-02 2019-09-03 付纪军 一种含聚乙烯己内酰胺-聚乙酸乙烯酯-聚乙二醇接枝共聚物的药物制剂及其制备方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3851052A (en) * 1972-11-08 1974-11-26 Pfizer Stabilized e-series prostaglandins
US4301175A (en) * 1980-12-29 1981-11-17 The Upjohn Company E-Type prostaglandin compositions
WO2015113094A1 (de) * 2014-01-30 2015-08-06 Gebro Holding Gmbh Stabile alkoholische lösung von alprostadil
WO2017015690A1 (de) * 2015-07-27 2017-02-02 Gebro Holding Gmbh Konzentrat enthaltend alprostadil

Also Published As

Publication number Publication date
WO2023119188A1 (en) 2023-06-29
EE202100026A (et) 2023-08-15

Similar Documents

Publication Publication Date Title
NO20083590L (no) Biocidblandinger inneholdende pyrition- og pyrrolderivativer
UA102574C2 (ru) 1-фенил-2-пиридинилалкил-спиртовые производные как ингибиторы фосфодиэстеразы
BRPI0017013B8 (pt) composição de antibiótico azalídeo e método para sua obtenção
EA201490709A1 (ru) Адъювантное соединение
MX2021002762A (es) Compuestos de isoxazolina para controlar plagas de invertebrados.
MY191795A (en) Diesel fuel composition containing additive
MX2020005077A (es) Compuestos con acción estabilizadora, procedimiento para su preparación, composición que contiene estos compuestos estabilizadores, procedimiento para la estabilización de un componente orgánico así como uso de compuestos estabilizadores.
PE20091359A1 (es) Proceso de preparacion de compuestos organicos intermediarios de inhibidores de renina
MX2021005710A (es) Compuestos de meta-diamida para controlar plagas de invertebrados.
BR112022007604A2 (pt) Composto de 3-n-ciclopropilmetil-2-fluorobenzamida. composto, e, uso do composto 3-n-ciclopropilmetil-2-fluorobenzamida
EE202100026A (et) 3-hüdroksütsüklopentoonitsüklit sisaldava ühendi kompositsioon ja meetod selle stabiliseerimiseks
MX2021000096A (es) Espuma de poliuretano o poliol de polieter estabilizados con un derivado de benzofuranona-fosfito.
CL2020003015A1 (es) Conversión a escala preparativa de goniautoxinas en neosaxitoxina
DE502006008630D1 (de) Kosmetische zusammensetzung zur stimulierung der synthese der proteine der basalmembran
US9909021B2 (en) Method for producing a coating agent
CR20200349A (es) Composiciones naftaleno isoxazolina para controlar plagas invertebrados
CR20210051A (es) Compuestos de isoxazolina para controlar plagas de invertebrados
WO2020242719A3 (en) Inhibitors of rna-binding proteins, compositions thereof, and therapeutic uses thereof
WO2017171665A3 (en) Coalescing agent derived from succinate ester
EP2415461A8 (en) Stabilization of interleukin 6 in serum based solutions
MX2018002777A (es) Mezcla de iniciador, composicion, su uso, proceso de preparacion de polimero de poliol y polimero de poliol obtenido por el proceso.
TW200604235A (en) Coating compositions for ambient cure containing an alkoxylated amine
NZ593327A (en) Compositions for the treatment of timber and other wood substrates
WO2016033166A4 (en) N-propyl bromide solvent systems
SG11201908282WA (en) Soybean-derived composition and method for producing same